- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04159324
StroCare - Optimised Cross-sectoral,Coordinated Treatment of Stroke Patients With Patient-orientated Outcome Measurement (StroCare)
December 22, 2023 updated by: Götz Thomalla, MD, Universitätsklinikum Hamburg-Eppendorf
StroCare - Optimised Cross-sectoral, Coordinated Treatment of Stroke Patients With Patient-orientated Outcome Measurement
The Trial is a multi-centred controlled interventional study with a pre-post design.
The primary aim of the study is the evaluation of the effectiveness and cost-effectiveness of the StroCare treatment.
Study Overview
Status
Completed
Conditions
Detailed Description
Stroke is the second most common cause of death in Germany and the most common cause for life-long disability in adulthood.
After stroke, patients often experience incisive changes in their health, daily routine and quality of life.
The developed model of care (StroCare treatment) forms a cross--sectoral, structured and coordinated treatment pathway that integrates a patient-centred outcome evaluation.
It aims to optimize the transition from acute inpatient treatment after an acute stroke to the ambulant neurological rehabilitation treatment.
This is done firstly by creating an electronic portal solution for a safe and coordinated transmission of clinical data between the three participating hospitals and five stroke-specialized ambulant rehabilitation clinics and secondly by introducing a case-manager provided by the participating health insurance agency for patient support and aftercare coordination.
The presented study is a multi-centred controlled interventional study with a pre-post design.
Stroke patients in both groups are assessed after the index ischemic event and 12 months thereafter.
Further sources of information are the medical record, the electronic portal (only intervention group), and routine data provided by the collaborating BARMER health insurance agency (for the Intervention and control group and additionally for a historic control).
The main hypotheses are : (1) The StroCare treatment is more effective than the routine aftercare treatment (primary outcome: patient-reported physical quality of life) and (2) the StroCare treatment reduces costs for care and in the inpatient sector by providing more coordinated and thorough rehabilitation and outpatient aftercare.
Study Type
Interventional
Enrollment (Actual)
409
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hamburg, Germany, 20246
- University Medical Center Hamburg-Eppendorf
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients in inpatient care in the stroke unit of one of the participating acute clinics who are insured at the BARMER health insurance agency with the following diagnosis (ICD-10):
- Ischemic attack (I63)
- Transient ischemic attack and related syndromes (G45)
- Intracerebral haermorrhage (I64)
- Written informed consent
- Sufficient mastery of German language
Exclusion Criteria:
- Substantially impaired communication capacity due to aphasia or dementia
- Patients with artificial Respiration
- Insufficient adherence
- Premorbid score of mRS≥4
- Patients with artificial Respiration (Z99.1)
- Dementia (F00.x., F01.x. or G30.x) or aphasia (R47)
- Death during inpatient Treatment or the Admission to a nursing home following the acute treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: StroCare treatment group
Optimized cross-sectoral, structured and coordinated treatment pathway that integrates a patient-centred outcome evaluation
|
the optimized treatment pathway includes coordinated transitions between rehabilitation phases and institutes using individual case management and portal solutions
|
No Intervention: control group
routine aftercare stroke treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient-reported physical QoL: PROMIS-10
Time Frame: 1 year after index ischemic event
|
Patient-reported physical Quality of Life measured with Patient-Reported Outcomes Measurement Information System-10 (PROMIS-10); one of two provided global scores: Global Physcial Health with scores ranging from 0-20 and higher scores indicating better health state.
|
1 year after index ischemic event
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient-reported mental health status
Time Frame: 1 year after index ischemic event
|
Patient reported mental health Status measured with the Patient health questionnaire (PHQ-4); the questionnaire provides two sub-scores measuring anxiety and depression with scores ranging from 0-6 each with higher scores indiciating more symptoms of anxiety or depression, respectively
|
1 year after index ischemic event
|
Functional Status modified Rankin Scale questionnaire (smRSq)
Time Frame: 1 year after index ischemic event
|
Functional Status measured with the modified Rankin Scale (mRS); the nRS ranges from 0 (no disability) to 6 (death)
|
1 year after index ischemic event
|
Overall survival
Time Frame: 1 year after index ischemic event
|
Overall survival measured with the ICHOM Standard set
|
1 year after index ischemic event
|
Stroke recurrence
Time Frame: 1 year after index ischemic event
|
Stroke recurrence measured with the ICHOM Standard set
|
1 year after index ischemic event
|
Utilisation of health care Services
Time Frame: 1 year after index ischemic event
|
Utilisation of health care Services extracted from the medical record and the electronic Portal (only Intervention Group), i.e., number of admissions to hospital, number of outpatient contacts, weekly hours of physiotherapy, speech therapy, occupational therapy
|
1 year after index ischemic event
|
Patient' s waiting time between Treatment phases (Transition) to the ambulant neurological Rehabilitation Treatment)
Time Frame: 1 year after index ischemic event
|
Waiting time extracted from the medical record and the electronic Portal (only Intervention Group)
|
1 year after index ischemic event
|
Success in reahin target values of relevant risk factors (individually defined target values based on available guidelines): blood pressure
Time Frame: 1 year after index ischemic event
|
Current values Blood Pressure will be extracted from the medical record and the electronic portal and compared to the individually defined target values based on current guidelines and individuall assessement of the overall patient's situation
|
1 year after index ischemic event
|
Success in reahin target values of relevant risk factors (individually defined target values based on available guidelines): LDL-cholesterol
Time Frame: 1 year after index ischemic event
|
Current values of LDL-cholesterol will be extracted from the medical record and the electronic portal and compared to the individually defined target values based on current guidelines and individuall assessement of the overall patient's situation
|
1 year after index ischemic event
|
Success in reahin target values of relevant risk factors (individually defined target values based on available guidelines): HbA1c
Time Frame: 1 year after index ischemic event
|
Current values of HbA1c will be extracted from the medical record and the electronic portal and compared to the individually defined target values based on current guidelines and individuall assessement of the overall patient's situation
|
1 year after index ischemic event
|
Costs
Time Frame: 1 year after index ischemic event
|
Routine data
|
1 year after index ischemic event
|
Patient-reported mental QoL
Time Frame: 1 year after index ischemic event
|
Patient-reported mental Quality of Life measured with Patient-Reported Outcomes Measurement Information System-10 (PROMIS-10); one of two provided global scores: Global Mental Health with scores ranging from 0-20 and higher scores indicating better health state.
|
1 year after index ischemic event
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Götz Thomalla, Prof. Dr., University Medical Centre Hamburg-Eppendorf
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2020
Primary Completion (Actual)
December 5, 2023
Study Completion (Actual)
December 5, 2023
Study Registration Dates
First Submitted
November 7, 2019
First Submitted That Met QC Criteria
November 8, 2019
First Posted (Actual)
November 12, 2019
Study Record Updates
Last Update Posted (Actual)
December 29, 2023
Last Update Submitted That Met QC Criteria
December 22, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 01NVF18022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey